Treating Amblyopia With CureSight
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Patients with visual acuity and ocular characteristics outside the Novasight FDA multi-center study are to perform the same Curesight procedures- including M\&S EVA or eETDRS patched acuity, stereo and then utilize the Curesight device 1.5 hours per day, 6 days per week over 3-6 months to determine treatment efficacy. An Eye-Tracking-Based Dichoptic Home Treatment for Amblyopia: A Multicenter Randomized Clinical Trial T. Wygnanski-Jaffe, B. J. Kushner, A. Moshkovitz, M. Belkin, O. Yehezkel and G. CureSight Pivotal Trial Ophthalmology 2023 Vol. 130 Issue 3 Pages 274-285
Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 20
Healthy Volunteers: t
View:
• amblyopia
Locations
United States
Alaska
Alaska Blind Child Discovery
RECRUITING
Anchorage
Contact Information
Primary
Robert W Arnold, MD
eyedoc@alaska.net
9075611917
Backup
Jennifer Plachinski
jplachinski@alaskachildrenseye.com
9075611917
Time Frame
Start Date: 2023-03-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 20
Treatments
Experimental: Amblyopia therapy with Curesight outside FDA limited ranges
Severity of amblyopia and age range outside FDA study
Related Therapeutic Areas
Sponsors
Leads: Alaska Blind Child Discovery